Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06451744

Cellular and Molecular Biomarkers in Patients With Lichen Planus

Led by Institut Pasteur · Updated on 2025-07-01

70

Participants Needed

6

Research Sites

182 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Lichen planus (LP) is a chronic inflammatory disease of unknown aetiology, affecting the skin and mucous membranes, characterised by a CD8+ cytotoxic T-cell infiltrate, associated with epithelial cell death and disruption of the basement membrane zone. In previous work, T cell antigen receptor (TCR) repertoire studies were performed. In all patients tested, whether with erosive or non-erosive LP, unique nucleotide sequences, called clonotypes, have been identified. They appear during the process of TCR gene rearrangement. These clonotypes are specific for human papillomavirus (HPV) in blood and lesions, suggesting antigenic stimulation of these clonotypes by a viral epitope of HPV, which crosses with an epitope on keratinocytes. The diagnosis of LP is made on the basis of clinical and histological criteria, but in some patients and in some anatomical locations, the diagnosis is difficult to make and LP may be confused with other skin conditions.

CONDITIONS

Official Title

Cellular and Molecular Biomarkers in Patients With Lichen Planus

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject diagnosed at the time of disease onset or during a progressive episode without systemic treatment or after stopping immunomodulatory or immunosuppressive treatment
  • Ability to provide written consent
  • Understands spoken and written French
  • Affiliated with French social security or similar systems
Not Eligible

You will not qualify if you...

  • Dermatosis only located in the skin folds or on the face due to biopsy scarring risk

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

CHU de Besançon

Besançon, France, 25030

Actively Recruiting

2

CHU Paris Seine-Saint-Denis- Hôpital Avicenne

Bobigny, France

Actively Recruiting

3

Centre Medical de l'Institut Pasteur

Paris, France, 75015

Actively Recruiting

4

Hôpital Saint-Louis

Paris, France

Actively Recruiting

5

Hôpital Robert Debré, CHU de Reims

Reims, France, 51092

Actively Recruiting

6

CHU de Rouen

Rouen, France

Actively Recruiting

Loading map...

Research Team

M

Marie-Lise Gougeon

CONTACT

S

Sandrine Fernandes Pellerin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

7

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here